{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:25Z","timestamp":1791895645814,"version":"4.3.4"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The primary intravenous anesthetics employed in clinical practice encompass dexmedetomidine (Dex), propofol, ketamine, etomidate, midazolam, and remimazolam. Apart from their established sedative, analgesic, and anxiolytic properties, an increasing body of research has uncovered neuroprotective effects of intravenous anesthetics in various animal and cellular models, as well as in clinical studies. However, there also exists conflicting evidence pointing to the potential neurotoxic effects of these intravenous anesthetics. The role of intravenous anesthetics for neuro on both sides of protection or toxicity has been rarely summarized. Considering the mentioned above, this work aims to offer a comprehensive understanding of the underlying mechanisms involved both in the central nerve system (CNS) and the peripheral nerve system (PNS) and provide valuable insights into the potential safety and risk associated with the clinical use of intravenous anesthetics.<\/jats:p>","DOI":"10.1007\/s12264-024-01265-4","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T15:02:05Z","timestamp":1723906925000},"page":"107-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Role of Intravenous Anesthetics for Neuro: Protection or Toxicity?"],"prefix":"10.1007","volume":"41","author":[{"given":"Kaixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"1265_CR1","doi-asserted-by":"crossref","unstructured":"Zheng B, Zhang S, Ying Y, Guo X, Li H, Xu L, et al. Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats. Biosci Rep 2018, 38: BSR20180892.","DOI":"10.1042\/BSR20180892"},{"key":"1265_CR2","first-page":"8079","volume":"17","author":"MH Zhang","year":"2018","unstructured":"Zhang MH, Zhou XM, Cui JZ, Wang KJ, Feng Y, Zhang HA. Neuroprotective effects of dexmedetomidine on traumatic brain injury: Involvement of neuronal apoptosis and HSP70 expression. Mol Med Rep 2018, 17: 8079\u20138086.","journal-title":"Mol Med Rep"},{"key":"1265_CR3","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/fsn3.1915","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Yang X, Han F, Gao L, Zhou Y. Propofol improves brain injury induced by chronic cerebral hypoperfusion in rats. Food Sci Nutr 2021, 9: 2801\u20132809.","journal-title":"Food Sci Nutr"},{"key":"1265_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/ALN.0000000000001730","volume":"127","author":"H Qiao","year":"2017","unstructured":"Qiao H, Li Y, Xu Z, Li W, Fu Z, Wang Y. Propofol affects neurodegeneration and neurogenesis by regulation of autophagy via effects on intracellular calcium homeostasis. Anesthesiology 2017, 127: 490\u2013501.","journal-title":"Anesthesiology"},{"key":"1265_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ANA.0b013e31817ec34d","volume":"20","author":"S Kahraman","year":"2008","unstructured":"Kahraman S, Zup SL, McCarthy MM, Fiskum G. GABAergic mechanism of propofol toxicity in immature neurons. J Neurosurg Anesthesiol 2008, 20: 233\u2013240.","journal-title":"J Neurosurg Anesthesiol"},{"key":"1265_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","volume":"10","author":"YB Sun","year":"2019","unstructured":"Sun YB, Zhao H, Mu DL, Zhang W, Cui J, Wu L, et al. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis 2019, 10: 167.","journal-title":"Cell Death Dis"},{"key":"1265_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/0028-3886.253616","volume":"67","author":"A Bindra","year":"2019","unstructured":"Bindra A, Kaushal A, Prabhakar H, Chaturvedi A, Chandra PS, Tripathi M, et al. Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study. Neurol India 2019, 67: 163\u2013168.","journal-title":"Neurol India"},{"key":"1265_CR8","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.113410","volume":"11","author":"IM Ibrahim","year":"2021","unstructured":"Ibrahim IM, Hassan R, Mostafa RH, Ibrahim MA. Efficacy of dexmedetomidine infusion without loading dose on hemodynamic variables and recovery time during craniotomy: A randomized double-blinded controlled study. Anesth Pain Med 2021, 11: e113410.","journal-title":"Anesth Pain Med"},{"key":"1265_CR9","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1177\/0300060519843738","volume":"47","author":"Y Ge","year":"2019","unstructured":"Ge Y, Li Q, Nie Y, Gao J, Luo K, Fang X, et al. Dexmedetomidine improves cognition after carotid endarterectomy by inhibiting cerebral inflammation and enhancing brain-derived neurotrophic factor expression. J Int Med Res 2019, 47: 2471\u20132482.","journal-title":"J Int Med Res"},{"key":"1265_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117359","volume":"247","author":"N Xing","year":"2020","unstructured":"Xing N, Xing F, Li Y, Li P, Zhang J, Wang D, et al. Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K\/Akt signaling pathway. Life Sci 2020, 247: 117359.","journal-title":"Life Sci"},{"key":"1265_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fncel.2019.00251","volume":"13","author":"W Li","year":"2019","unstructured":"Li W, Li H, Wei H, Lu Y, Lei S, Zheng J, et al. 17\u03b2-estradiol treatment attenuates neurogenesis damage and improves behavior performance after ketamine exposure in neonatal rats. Front Cell Neurosci 2019, 13: 251.","journal-title":"Front Cell Neurosci"},{"key":"1265_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134647","volume":"716","author":"CY Zhang","year":"2020","unstructured":"Zhang CY, Du J, Zhang R, Jin J, Qiao LY. Erythropoietin attenuates propofol-induced hippocampal neuronal cell injury in developing rats by inhibiting toll-like receptor 4 expression. Neurosci Lett 2020, 716: 134647.","journal-title":"Neurosci Lett"},{"key":"1265_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijdevneu.2009.06.010","volume":"27","author":"X Zou","year":"2009","unstructured":"Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, Hanig JP, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 2009, 27: 727\u2013731.","journal-title":"Int J Dev Neurosci"},{"key":"1265_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/bja\/aet066","volume":"110","author":"FW Abdallah","year":"2013","unstructured":"Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: A systematic review and meta-analysis. Br J Anaesth 2013, 110: 915\u2013925.","journal-title":"Br J Anaesth"},{"key":"1265_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/bja\/aew411","volume":"118","author":"L Vorobeichik","year":"2017","unstructured":"Vorobeichik L, Brull R, Abdallah FW. Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: A systematic review and meta-analysis of randomized controlled trials. Br J Anaesth 2017, 118: 167\u2013181.","journal-title":"Br J Anaesth"},{"key":"1265_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/bja\/aes400","volume":"110","author":"D Marhofer","year":"2013","unstructured":"Marhofer D, Kettner SC, Marhofer P, Pils S, Weber M, Zeitlinger M. Dexmedetomidine as an adjuvant to ropivacaine prolongs peripheral nerve block: A volunteer study. Br J Anaesth 2013, 110: 438\u2013442.","journal-title":"Br J Anaesth"},{"key":"1265_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/ALN.0b013e318182c26b","volume":"109","author":"CM Brummett","year":"2008","unstructured":"Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology 2008, 109: 502\u2013511.","journal-title":"Anesthesiology"},{"key":"1265_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114210","volume":"182","author":"FLP da Costa","year":"2020","unstructured":"da Costa FLP, Pinto MCX, Santos DC, Carobin NV, de Jesus ICG, Ferreira LA, et al. Ketamine potentiates TRPV1 receptor signaling in the peripheral nociceptive pathways. Biochem Pharmacol 2020, 182: 114210.","journal-title":"Biochem Pharmacol"},{"key":"1265_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/rapm.2002.35517","volume":"27","author":"T Ushida","year":"2002","unstructured":"Ushida T, Tani T, Kanbara T, Zinchuk VS, Kawasaki M, Yamamoto H. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med 2002, 27: 524\u2013528.","journal-title":"Reg Anesth Pain Med"},{"key":"1265_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jclinane.2011.02.013","volume":"24","author":"JM Hesselink","year":"2012","unstructured":"Hesselink JM, Kopsky DJ. Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%. J Clin Anesth 2012, 24: 78\u201379.","journal-title":"J Clin Anesth"},{"key":"1265_CR21","doi-asserted-by":"crossref","unstructured":"O\u2019Connell NE, Wand BM, McAuley J, Marston L, Moseley GL. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev 2013, 2013: CD009416.","DOI":"10.1002\/14651858.CD009416.pub2"},{"key":"1265_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1212\/01.WNL.0000055848.00032.39","volume":"60","author":"D Quan","year":"2003","unstructured":"Quan D, Wellish M, Gilden DH. Topical ketamine treatment of postherpetic neuralgia. Neurology 2003, 60: 1391\u20131392.","journal-title":"Neurology"},{"key":"1265_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/iub.1713","volume":"70","author":"J Chen","year":"2018","unstructured":"Chen J, Li H, Lim G, McCabe MF, Zhao W, Yang Y, et al. Different effects of dexmedetomidine and midazolam on the expression of NR2B and GABAA-\u03b11 following peripheral nerve injury in rats. IUBMB Life 2018, 70: 143\u2013152.","journal-title":"IUBMB Life"},{"key":"1265_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.04.016","volume":"132","author":"JR Wu","year":"2017","unstructured":"Wu JR, Chen H, Yao YY, Zhang MM, Jiang K, Zhou B, et al. Local injection to sciatic nerve of dexmedetomidine reduces pain behaviors, SGCs activation, NGF expression and sympathetic sprouting in CCI rats. Brain Res Bull 2017, 132: 118\u2013128.","journal-title":"Brain Res Bull"},{"key":"1265_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/WNR.0000000000001068","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, Xia Z, Meng Q, Liu K, Xiao Y, Shi L. Dexmedetomidine relieves neuropathic pain by inhibiting hyperpolarization-activated cyclic nucleotide-gated currents in dorsal root Ganglia neurons. Neuroreport 2018, 29: 1001\u20131006.","journal-title":"Neuroreport"},{"key":"1265_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.asjsur.2015.10.009","volume":"40","author":"X Huang","year":"2017","unstructured":"Huang X, Deng R, Tu W, Hu Z. Dexmedetomidine reduces neuropathic pain in a rat model of skin\/muscle incision and retraction. Asian J Surg 2017, 40: 35\u201340.","journal-title":"Asian J Surg"},{"key":"1265_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2020.00790","volume":"11","author":"T Yang","year":"2020","unstructured":"Yang T, Feng X, Zhao Y, Zhang H, Cui H, Wei M, et al. Dexmedetomidine enhances autophagy via \u03b12-AR\/AMPK\/mTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury. Front Pharmacol 2020, 11: 790.","journal-title":"Front Pharmacol"},{"key":"1265_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2019.0234","volume":"321","author":"B Subramaniam","year":"2019","unstructured":"Subramaniam B, Shankar P, Shaefi S, Mueller A, O\u2019Gara B, Banner-Goodspeed V, et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: The DEXACET randomized clinical trial. JAMA 2019, 321: 686\u2013696.","journal-title":"JAMA"},{"key":"1265_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12871-020-01211-7","volume":"20","author":"X Zheng","year":"2020","unstructured":"Zheng X, Cai X, Ye F, Li Y, Wang Q, Zuo Z, et al. Perioperative Dexmedetomidine attenuates brain ischemia reperfusion injury possibly via up-regulation of astrocyte Connexin 43. BMC Anesthesiol 2020, 20: 299.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11357-020-00281-2","volume":"43","author":"F Vasilopoulou","year":"2021","unstructured":"Vasilopoulou F, Gri\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Ab\u00e1s S, Escolano C, et al. I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway. GeroScience 2021, 43: 965\u2013983.","journal-title":"GeroScience"},{"key":"1265_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(20)30631-0","volume":"396","author":"A Turan","year":"2020","unstructured":"Turan A, Duncan A, Leung S, Karimi N, Fang J, Mao G, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): A randomised placebo-controlled trial. Lancet 2020, 396: 177\u2013185.","journal-title":"Lancet"},{"key":"1265_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015709","volume":"98","author":"B Wu","year":"2019","unstructured":"Wu B, Hu H, Cai A, Ren C, Liu S. The safety and efficacy of dexmedetomidine versus propofol for patients undergoing endovascular therapy for acute stroke: A prospective randomized control trial. Medicine 2019, 98: e15709.","journal-title":"Medicine"},{"key":"1265_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2044.2007.05306.x","volume":"63","author":"BM Biccard","year":"2008","unstructured":"Biccard BM, Goga S, de Beurs J. Dexmedetomidine and cardiac protection for non-cardiac surgery: A meta-analysis of randomised controlled trials. Anaesthesia 2008, 63: 4\u201314.","journal-title":"Anaesthesia"},{"key":"1265_CR34","doi-asserted-by":"publisher","first-page":"4035310","DOI":"10.1155\/2018\/4035310","volume":"2018","author":"Y Chen","year":"2018","unstructured":"Chen Y, Feng X, Hu X, Sha J, Li B, Zhang H, et al. Dexmedetomidine ameliorates acute stress-induced kidney injury by attenuating oxidative stress and apoptosis through inhibition of the ROS\/JNK signaling pathway. Oxid Med Cell Longev 2018, 2018: 4035310.","journal-title":"Oxid Med Cell Longev"},{"key":"1265_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molimm.2017.12.008","volume":"94","author":"L Meng","year":"2018","unstructured":"Meng L, Li L, Lu S, Li K, Su Z, Wang Y, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4\/NF-\u03baB and PI3K\/Akt\/mTOR pathways. Mol Immunol 2018, 94: 7\u201317.","journal-title":"Mol Immunol"},{"key":"1265_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2019.06.004","volume":"152","author":"H Fang","year":"2019","unstructured":"Fang H, Li HF, He MH, Yan JY, Yang M, Zhang FX, et al. Long non-coding RNA MALAT1 sponges microRNA-429 to regulate apoptosis of hippocampal neurons in hypoxic-ischemic brain damage by regulating WNT1. Brain Res Bull 2019, 152: 1\u201310.","journal-title":"Brain Res Bull"},{"key":"1265_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.biopha.2018.11.143","volume":"110","author":"G Zhang","year":"2019","unstructured":"Zhang G, Ge M, Han Z, Wang S, Yin J, Peng L, et al. Wnt\/\u03b2-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factor\u03b21\/Smad3 signaling pathway. Biomed Pharmacother 2019, 110: 420\u2013430.","journal-title":"Biomed Pharmacother"},{"key":"1265_CR38","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.01.016","volume":"28","author":"J Huang","year":"2019","unstructured":"Huang J, Jiang Q. Dexmedetomidine protects against neurological dysfunction in a mouse intracerebral hemorrhage model by inhibiting mitochondrial dysfunction-derived oxidative stress. J Stroke Cerebrovasc Dis 2019, 28: 1281\u20131289.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1265_CR39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fnins.2018.00964","volume":"12","author":"Y Shan","year":"2018","unstructured":"Shan Y, Yang F, Tang Z, Bi C, Sun S, Zhang Y, et al. Dexmedetomidine ameliorates the neurotoxicity of sevoflurane on the immature brain through the BMP\/SMAD signaling pathway. Front Neurosci 2018, 12: 964.","journal-title":"Front Neurosci"},{"key":"1265_CR40","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1177\/09603271211023784","volume":"40","author":"YJ Li","year":"2021","unstructured":"Li YJ, Zhang DZ, Xi Y, Wu CA. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134. Hum Exp Toxicol 2021, 40: 2145\u20132155.","journal-title":"Hum Exp Toxicol"},{"key":"1265_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104493","volume":"129","author":"KM Chiu","year":"2019","unstructured":"Chiu KM, Lin TY, Lee MY, Lu CW, Wang MJ, Wang SJ. Dexmedetomidine protects neurons from kainic acid-induced excitotoxicity by activating BDNF signaling. Neurochem Int 2019, 129: 104493.","journal-title":"Neurochem Int"},{"key":"1265_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijdevneu.2019.04.002","volume":"75","author":"T Goyagi","year":"2019","unstructured":"Goyagi T. Dexmedetomidine reduced sevoflurane-induced neurodegeneration and long-term memory deficits in neonatal rats. Int J Dev Neurosci 2019, 75: 19\u201326.","journal-title":"Int J Dev Neurosci"},{"key":"1265_CR43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000542-199609000-00014","volume":"85","author":"P Talke","year":"1996","unstructured":"Talke P, Bickler PE. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 1996, 85: 551\u2013557.","journal-title":"Anesthesiology"},{"key":"1265_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00004647-200006000-00001","volume":"20","author":"R Huang","year":"2000","unstructured":"Huang R, Chen Y, Yu AC, Hertz L. Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: A possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metab 2000, 20: 895\u2013898.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1265_CR45","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.4161\/cbt.8.19.9762","volume":"8","author":"E Noch","year":"2009","unstructured":"Noch E, Khalili K. Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity. Cancer Biol Ther 2009, 8: 1791\u20131797.","journal-title":"Cancer Biol Ther"},{"key":"1265_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/DDDT.S163197","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang X, Shan Y, Tang Z, Gao L, Liu H. Neuroprotective effects of dexmedetomidine against isoflurane-induced neuronal injury via glutamate regulation in neonatal rats. Drug Des Devel Ther 2018, 13: 153\u2013160.","journal-title":"Drug Des Devel Ther"},{"key":"1265_CR47","first-page":"2323","volume":"18","author":"M Ding","year":"2019","unstructured":"Ding M, Chen Y, Luan H, Zhang X, Zhao Z, Wu Y. Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes. Exp Ther Med 2019, 18: 2323\u20132331.","journal-title":"Exp Ther Med"},{"key":"1265_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.977941","volume":"15","author":"H Guo","year":"2022","unstructured":"Guo H, Zhang W, Wang Z, Li Z, Zhou J, Yang Z. Dexmedetomidine post-conditioning protects blood-brain barrier integrity by modulating microglia\/macrophage polarization via inhibiting NF-\u03baB signaling pathway in intracerebral hemorrhage. Front Mol Neurosci 2022, 15: 977941.","journal-title":"Front Mol Neurosci"},{"key":"1265_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113006","volume":"150","author":"J Wang","year":"2022","unstructured":"Wang J, Xin Y, Chu T, Liu C, Xu A. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1\/RAGE\/NF-\u03baB signaling pathway. Biomed Pharmacother 2022, 150: 113006.","journal-title":"Biomed Pharmacother"},{"key":"1265_CR50","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1248\/bpb.b20-00482","volume":"44","author":"XD Ding","year":"2021","unstructured":"Ding XD, Cao YY, Li L, Zhao GY. Dexmedetomidine reduces the lidocaine-induced neurotoxicity by inhibiting inflammasome activation and reducing pyroptosis in rats. Biol Pharm Bull 2021, 44: 902\u2013909.","journal-title":"Biol Pharm Bull"},{"key":"1265_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jclinane.2017.04.003","volume":"40","author":"L Jiang","year":"2017","unstructured":"Jiang L, Hu M, Lu Y, Cao Y, Chang Y, Dai Z. The protective effects of dexmedetomidine on ischemic brain injury: A meta-analysis. J Clin Anesth 2017, 40: 25\u201332.","journal-title":"J Clin Anesth"},{"key":"1265_CR52","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1021\/acs.jafc.8b00437","volume":"66","author":"PS Wu","year":"2018","unstructured":"Wu PS, Ding HY, Yen JH, Chen SF, Lee KH, Wu MJ. Anti-inflammatory activity of 8-hydroxydaidzein in LPS-stimulated BV2 microglial cells via activation of Nrf2-antioxidant and attenuation of akt\/NF-\u03baB-inflammatory signaling pathways, as well As inhibition of COX-2 activity. J Agric Food Chem 2018, 66: 5790\u20135801.","journal-title":"J Agric Food Chem"},{"key":"1265_CR53","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/acn3.50878","volume":"6","author":"F Li","year":"2019","unstructured":"Li F, Wang X, Zhang Z, Zhang X, Gao P. Dexmedetomidine Attenuates Neuroinflammatory-Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway. Ann Clin Transl Neurol 2019, 6: 1825\u20131835.","journal-title":"Ann Clin Transl Neurol"},{"key":"1265_CR54","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3892\/etm.2021.10479","volume":"22","author":"W Shan","year":"2021","unstructured":"Shan W, Liao X, Tang Y, Liu J. Dexmedetomidine alleviates inflammation in neuropathic pain by suppressing NLRP3 via Nrf2 activation. Exp Ther Med 2021, 22: 1046.","journal-title":"Exp Ther Med"},{"key":"1265_CR55","doi-asserted-by":"publisher","first-page":"6643171","DOI":"10.1155\/2021\/6643171","volume":"2021","author":"X Chen","year":"2021","unstructured":"Chen X, Chen D, Li Q, Wu S, Pan J, Liao Y, et al. Dexmedetomidine alleviates hypoxia-induced synaptic loss and cognitive impairment via inhibition of microglial NOX2 activation in the hippocampus of neonatal rats. Oxid Med Cell Longev 2021, 2021: 6643171.","journal-title":"Oxid Med Cell Longev"},{"key":"1265_CR56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainres.2018.09.007","volume":"1701","author":"C Liu","year":"2018","unstructured":"Liu C, Fu Q, Mu R, Wang F, Zhou C, Zhang L, et al. Dexmedetomidine alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress dependent apoptosis through the PERK-CHOP-Caspase-11 pathway. Brain Res 2018, 1701: 246\u2013254.","journal-title":"Brain Res"},{"key":"1265_CR57","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1111\/jcmm.14688","volume":"23","author":"L Zhao","year":"2019","unstructured":"Zhao L, Zhai M, Yang X, Guo H, Cao Y, Wang D, et al. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling. J Cell Mol Med 2019, 23: 8173\u20138183.","journal-title":"J Cell Mol Med"},{"key":"1265_CR58","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.18632\/aging.102404","volume":"11","author":"M Zhai","year":"2019","unstructured":"Zhai M, Liu C, Li Y, Zhang P, Yu Z, Zhu H, et al. Dexmedetomidine inhibits neuronal apoptosis by inducing Sigma-1 receptor signaling in cerebral ischemia-reperfusion injury. Aging 2019, 11: 9556\u20139568.","journal-title":"Aging"},{"key":"1265_CR59","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2022e12145","volume":"55","author":"H Liu","year":"2022","unstructured":"Liu H, Li J, Jiang L, He J, Zhang H, Wang K. Dexmedetomidine pretreatment alleviates cerebral ischemia\/reperfusion injury by inhibiting neuroinflammation through the JAK2\/STAT3 pathway. Braz J Med Biol Res 2022, 55: e12145.","journal-title":"Braz J Med Biol Res"},{"key":"1265_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.899484","volume":"16","author":"B Wei","year":"2022","unstructured":"Wei B, Liu W, Jin L, Guo S, Fan H, Jin F, et al. Dexmedetomidine inhibits gasdermin D-induced pyroptosis via the PI3K\/AKT\/GSK3\u03b2 pathway to attenuate neuroinflammation in early brain injury after subarachnoid hemorrhage in rats. Front Cell Neurosci 2022, 16: 899484.","journal-title":"Front Cell Neurosci"},{"key":"1265_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2013.12.027","volume":"724","author":"M Shiomi","year":"2014","unstructured":"Shiomi M, Miyamae M, Takemura G, Kaneda K, Inamura Y, Onishi A, et al. Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen with prolonged ischemic insult. Eur J Pharmacol 2014, 724: 58\u201366.","journal-title":"Eur J Pharmacol"},{"key":"1265_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/2045-9912.215751","volume":"7","author":"F Ye","year":"2017","unstructured":"Ye F, Zuo ZY. Anesthetic effects on autophagy. Med Gas Res 2017, 7: 204\u2013211.","journal-title":"Med Gas Res"},{"key":"1265_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2021.12300","volume":"24","author":"X Feng","year":"2021","unstructured":"Feng X, Ma W, Zhu J, Jiao W, Wang Y. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS\/Nrf2 signaling pathway. Mol Med Rep 2021, 24: 661.","journal-title":"Mol Med Rep"},{"key":"1265_CR64","doi-asserted-by":"publisher","first-page":"21687","DOI":"10.18632\/aging.103975","volume":"12","author":"H Li","year":"2020","unstructured":"Li H, Lu C, Yao W, Xu L, Zhou J, Zheng B. Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b\/miR-27a-3p\/Dram2 pathway in a rat model of traumatic brain injury. Aging 2020, 12: 21687\u201321705.","journal-title":"Aging"},{"key":"1265_CR65","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fphar.2020.00128","volume":"11","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Feng X, Li B, Sha J, Wang C, Yang T, et al. Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K\/AKT\/mTOR pathway. Front Pharmacol 2020, 11: 128.","journal-title":"Front Pharmacol"},{"key":"1265_CR66","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1080\/15548627.2021.1900498","volume":"17","author":"J Li","year":"2021","unstructured":"Li J, Tian M, Hua T, Wang H, Yang M, Li W, et al. Combination of autophagy and NFE2L2\/NRF2 activation as a treatment approach for neuropathic pain. Autophagy 2021, 17: 4062\u20134082.","journal-title":"Autophagy"},{"key":"1265_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101954","volume":"41","author":"J Shi","year":"2021","unstructured":"Shi J, Yu T, Song K, Du S, He S, Hu X, et al. Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a\/HO-1 signaling pathway. Redox Biol 2021, 41: 101954.","journal-title":"Redox Biol"},{"key":"1265_CR68","first-page":"533","volume":"19","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jia A, Ma W. Dexmedetomidine attenuates the toxicity of \u03b2-amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5. Mol Med Rep 2019, 19: 533\u2013540.","journal-title":"Mol Med Rep"},{"key":"1265_CR69","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuint.2011.01.013","volume":"58","author":"M Yan","year":"2011","unstructured":"Yan M, Dai H, Ding T, Dai A, Zhang F, Yu L, et al. Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells. Neurochem Int 2011, 58: 549\u2013557.","journal-title":"Neurochem Int"},{"key":"1265_CR70","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1007\/s12035-020-02223-7","volume":"58","author":"H Lv","year":"2021","unstructured":"Lv H, Li Y, Cheng Q, Chen J, Chen W. Neuroprotective effects against cerebral ischemic injury exerted by dexmedetomidine via the HDAC5\/NPAS4\/MDM2\/PSD-95 axis. Mol Neurobiol 2021, 58: 1990\u20132004.","journal-title":"Mol Neurobiol"},{"key":"1265_CR71","first-page":"4","volume":"21","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ren Y, Jiang H, Huang Y. Dexmedetomidine inhibits the PSD95-NMDA receptor interaction to promote functional recovery following traumatic brain injury. Exp Ther Med 2021, 21: 4.","journal-title":"Exp Ther Med"},{"key":"1265_CR72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/brainsci8020036","volume":"8","author":"M Xiong","year":"2018","unstructured":"Xiong M, Shiwalkar N, Reddy K, Shin P, Bekker A. Neurobiology of propofol addiction and supportive evidence: What is the new development? Brain Sci 2018, 8: 36.","journal-title":"Brain Sci"},{"key":"1265_CR73","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nn913","volume":"5","author":"LE Nelson","year":"2002","unstructured":"Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002, 5: 979\u2013984.","journal-title":"Nat Neurosci"},{"key":"1265_CR74","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.2174\/1381612043382846","volume":"10","author":"PE Marik","year":"2004","unstructured":"Marik PE. Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004, 10: 3639\u20133649.","journal-title":"Curr Pharm Des"},{"key":"1265_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10753-017-0658-6","volume":"41","author":"X Zheng","year":"2018","unstructured":"Zheng X, Huang H, Liu J, Li M, Liu M, Luo T. Propofol attenuates inflammatory response in LPS-activated microglia by regulating the miR-155\/SOCS1 pathway. Inflammation 2018, 41: 11\u201319.","journal-title":"Inflammation"},{"key":"1265_CR76","doi-asserted-by":"publisher","first-page":"3101146","DOI":"10.1155\/2021\/3101146","volume":"2021","author":"X Xiao","year":"2021","unstructured":"Xiao X, Hou Y, Yu W, Qi S. Propofol ameliorates microglia activation by targeting microRNA-221\/222-IRF2 axis. J Immunol Res 2021, 2021: 3101146.","journal-title":"J Immunol Res"},{"key":"1265_CR77","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1248\/bpb.b20-00050","volume":"43","author":"Z Ma","year":"2020","unstructured":"Ma Z, Li K, Chen P, Pan J, Li X, Zhao G. Propofol attenuates inflammatory damage via inhibiting NLRP1-Casp1-Casp6 signaling in ischemic brain injury. Biol Pharm Bull 2020, 43: 1481\u20131489.","journal-title":"Biol Pharm Bull"},{"key":"1265_CR78","doi-asserted-by":"publisher","first-page":"4754454","DOI":"10.1155\/2021\/4754454","volume":"2021","author":"Y Hou","year":"2021","unstructured":"Hou Y, Xiao X, Yu W, Qi S. Propofol suppresses microglia inflammation by targeting TGM2\/NF- \u03ba B signaling. J Immunol Res 2021, 2021: 4754454.","journal-title":"J Immunol Res"},{"key":"1265_CR79","doi-asserted-by":"publisher","first-page":"8978704","DOI":"10.1155\/2020\/8978704","volume":"2020","author":"X Peng","year":"2020","unstructured":"Peng X, Li C, Yu W, Liu S, Cong Y, Fan G, et al. Propofol attenuates hypoxia-induced inflammation in BV2 microglia by inhibiting oxidative stress and NF-\u03baB\/hif-1\u03b1 signaling. Biomed Res Int 2020, 2020: 8978704.","journal-title":"Biomed Res Int"},{"key":"1265_CR80","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5114\/fn.2017.68579","volume":"55","author":"S Liu","year":"2017","unstructured":"Liu S, Sun JY, Ren LP, Chen K, Xu B. Propofol attenuates intermittent hypoxia induced up-regulation of proinflammatory cytokines in microglia through inhibiting the activation of NF-B\u03ba\/p38 MAPK signalling. Folia Neuropathol 2017, 55: 124\u2013131.","journal-title":"Folia Neuropathol"},{"key":"1265_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178098","volume":"12","author":"Y Lu","year":"2017","unstructured":"Lu Y, Gu Y, Ding X, Wang J, Chen J, Miao C. Intracellular Ca2+ homeostasis and JAK1\/STAT3 pathway are involved in the protective effect of propofol on BV2 microglia against hypoxia-induced inflammation and apoptosis. PLoS One 2017, 12: e0178098.","journal-title":"PLoS One"},{"key":"1265_CR82","doi-asserted-by":"publisher","first-page":"8868839","DOI":"10.1155\/2020\/8868839","volume":"2020","author":"A Qi","year":"2020","unstructured":"Qi A, Cao Y, Wang A. Ketamine and propofol protect neuron cells from oxygen-glucose deprivation-induced injury through SAPK\/JNK signalling pathway. Biomed Res Int 2020, 2020: 8868839.","journal-title":"Biomed Res Int"},{"key":"1265_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12871-018-0660-z","volume":"18","author":"M He","year":"2018","unstructured":"He M, Sun H, Pang J, Guo X, Huo Y, Wu X, et al. Propofol alleviates hypoxia-induced nerve injury in PC-12 cells by up-regulation of microRNA-153. BMC Anesthesiol 2018, 18: 197.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/ANA.0000000000000648","volume":"33","author":"M Balasubramanian","year":"2021","unstructured":"Balasubramanian M, Kuberan A, Rawat A, Dhandapani S, Panda N, Kumar A, et al. Effect of general anesthetics on caspase-3 levels in patients with aneurysmal subarachnoid hemorrhage: A preliminary study. J Neurosurg Anesthesiol 2021, 33: 172\u2013176.","journal-title":"J Neurosurg Anesthesiol"},{"key":"1265_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neulet.2017.04.019","volume":"649","author":"N Yang","year":"2017","unstructured":"Yang N, Li L, Li Z, Ni C, Cao Y, Liu T, et al. Protective effect of dapsone on cognitive impairment induced by propofol involves hippocampal autophagy. Neurosci Lett 2017, 649: 85\u201392.","journal-title":"Neurosci Lett"},{"key":"1265_CR86","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4161\/auto.6412","volume":"4","author":"YD Wen","year":"2008","unstructured":"Wen YD, Sheng R, Zhang LS, Han R, Zhang X, Zhang XD, et al. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy 2008, 4: 762\u2013769.","journal-title":"Autophagy"},{"key":"1265_CR87","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","volume":"14","author":"J Liu","year":"2018","unstructured":"Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, et al. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy 2018, 14: 845\u2013861.","journal-title":"Autophagy"},{"key":"1265_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109018","volume":"711","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ji D, Sun J, Song J, Nie L, Sun N. NPAS4 suppresses propofol-induced neurotoxicity by inhibiting autophagy in hippocampal neuronal cells. Arch Biochem Biophys 2021, 711: 109018.","journal-title":"Arch Biochem Biophys"},{"key":"1265_CR89","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s10020-018-0054-1","volume":"24","author":"B Sun","year":"2018","unstructured":"Sun B, Ou H, Ren F, Huan Y, Zhong T, Gao M, et al. Propofol inhibited autophagy through Ca2+\/CaMKK\u03b2\/AMPK\/mTOR pathway in OGD\/R-induced neuron injury. Mol Med 2018, 24: 58.","journal-title":"Mol Med"},{"key":"1265_CR90","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1021\/acschemneuro.1c00059","volume":"12","author":"B Sun","year":"2021","unstructured":"Sun B, Ou H, Ren F, Guan Y, Huan Y, Cai H. Propofol protects against cerebral ischemia\/reperfusion injury by down-regulating long noncoding RNA SNHG14. ACS Chem Neurosci 2021, 12: 3002\u20133014.","journal-title":"ACS Chem Neurosci"},{"key":"1265_CR91","first-page":"9650","volume":"24","author":"HS Zhang","year":"2020","unstructured":"Zhang HS, Liu CD, Zheng MC, Zhao HT, Liu XJ. Propofol alleviates hypoxic neuronal injury by inhibiting high levels of mitochondrial fusion and fission. Eur Rev Med Pharmacol Sci 2020, 24: 9650\u20139657.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1265_CR92","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12264-019-00426-0","volume":"36","author":"Y Wang","year":"2020","unstructured":"Wang Y, Tian D, Wei C, Cui V, Wang H, Zhu Y, et al. Propofol attenuates \u03b1-synuclein aggregation and neuronal damage in a mouse model of ischemic stroke. Neurosci Bull 2020, 36: 289\u2013298.","journal-title":"Neurosci Bull"},{"key":"1265_CR93","doi-asserted-by":"publisher","first-page":"1725191","DOI":"10.1155\/2018\/1725191","volume":"2018","author":"X Li","year":"2018","unstructured":"Li X, Yao L, Liang Q, Qu H, Cai H. Propofol protects hippocampal neurons from hypoxia-reoxygenation injury by decreasing calcineurin-induced calcium overload and activating YAP signaling. Oxid Med Cell Longev 2018, 2018: 1725191.","journal-title":"Oxid Med Cell Longev"},{"key":"1265_CR94","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/00000539-200111000-00030","volume":"93","author":"R Daskalopoulos","year":"2001","unstructured":"Daskalopoulos R, Korcok J, Farhangkhgoee P, Karmazyn M, Gelb AW, Wilson JX. Propofol protection of sodium-hydrogen exchange activity sustains glutamate uptake during oxidative stress. Anesth Analg 2001, 93: 1199\u20131204.","journal-title":"Anesth Analg"},{"key":"1265_CR95","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3109\/02699052.2014.947624","volume":"28","author":"DX Zhang","year":"2014","unstructured":"Zhang DX, Ding HZ, Jiang S, Zeng YM, Tang QF. An in vitro study of the neuroprotective effect of propofol on hypoxic hippocampal slice. Brain Inj 2014, 28: 1758\u20131765.","journal-title":"Brain Inj"},{"key":"1265_CR96","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/jcbfm.2013.118","volume":"33","author":"AM Fukuda","year":"2013","unstructured":"Fukuda AM, Adami A, Pop V, Bellone JA, Coats JS, Hartman RE, et al. Posttraumatic reduction of edema with aquaporin-4 RNA interference improves acute and chronic functional recovery. J Cereb Blood Flow Metab 2013, 33: 1621\u20131632.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1265_CR97","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12264-021-00653-4","volume":"37","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tian D, Zhao Y, Qu M, Pan Y, Wei C, et al. Propofol protects regulatory T cells, suppresses neurotoxic astrogliosis, and potentiates neurological recovery after ischemic stroke. Neurosci Bull 2021, 37: 725\u2013728.","journal-title":"Neurosci Bull"},{"key":"1265_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.637233","volume":"9","author":"T Zhang","year":"2021","unstructured":"Zhang T, Wang Y, Xia Q, Tu Z, Sun J, Jing Q, et al. Propofol mediated protection of the brain from ischemia\/reperfusion injury through the regulation of microglial connexin 43. Front Cell Dev Biol 2021, 9: 637233.","journal-title":"Front Cell Dev Biol"},{"key":"1265_CR99","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13054-015-1112-5","volume":"19","author":"A Kraj\u010dov\u00e1","year":"2015","unstructured":"Kraj\u010dov\u00e1 A, Waldauf P, And\u011bl M, Du\u0161ka F. Propofol infusion syndrome: A structured review of experimental studies and 153 published case reports. Crit Care 2015, 19: 398.","journal-title":"Crit Care"},{"key":"1265_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102079","volume":"8","author":"Q Liu","year":"2021","unstructured":"Liu Q, Sheng Z, Cheng C, Zheng H, Lanuti M, Liu R, et al. Anesthetic propofol promotes tumor metastasis in lungs via GABAA R-dependent TRIM21 modulation of src expression. Adv Sci 2021, 8: e2102079.","journal-title":"Adv Sci"},{"key":"1265_CR101","unstructured":"Secor T, Safadi AO, Gunderson S. Propofol toxicity. StatPearls 2022"},{"key":"1265_CR102","first-page":"1837","volume":"20","author":"R Guan","year":"2019","unstructured":"Guan R, Lv J, Xiao F, Tu Y, Xie Y, Li L. Potential role of the cAMP\/PKA\/CREB signalling pathway in hypoxic preconditioning and effect on propofol-induced neurotoxicity in the hippocampus of neonatal rats. Mol Med Rep 2019, 20: 1837\u20131845.","journal-title":"Mol Med Rep"},{"key":"1265_CR103","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00000542-200208000-00023","volume":"97","author":"L Pain","year":"2002","unstructured":"Pain L, Angst MJ, LeGourrier L, Oberling P. Effect of a nonsedative dose of propofol on memory for aversively loaded information in rats. Anesthesiology 2002, 97: 447\u2013453.","journal-title":"Anesthesiology"},{"key":"1265_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064480","volume":"8","author":"T Karen","year":"2013","unstructured":"Karen T, Schlager GW, Bendix I, Sifringer M, Herrmann R, Pantazis C, et al. Effect of propofol in the immature rat brain on short- and long-term neurodevelopmental outcome. PLoS One 2013, 8: e64480.","journal-title":"PLoS One"},{"key":"1265_CR105","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1521-6896(03)00005-3","volume":"17","author":"AY Bekker","year":"2003","unstructured":"Bekker AY, Weeks EJ. Cognitive function after anaesthesia in the elderly. Best Pract Res Clin Anaesthesiol 2003, 17: 259\u2013272.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1265_CR106","first-page":"5428","volume":"17","author":"L Wu","year":"2018","unstructured":"Wu L, Wang S, Feng Y, Zhao W, Zuo W, Zhong L, et al. KIF17 mediates the learning and memory impairment in offspring induced by maternal exposure to propofol during middle pregnancy. Mol Med Rep 2018, 17: 5428\u20135434.","journal-title":"Mol Med Rep"},{"key":"1265_CR107","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jcrc.2019.12.021","volume":"56","author":"MA Hausburg","year":"2020","unstructured":"Hausburg MA, Banton KL, Roman PE, Salgado F, Baek P, Waxman MJ, et al. Effects of propofol on ischemia-reperfusion and traumatic brain injury. J Crit Care 2020, 56: 281\u2013287.","journal-title":"J Crit Care"},{"key":"1265_CR108","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","volume":"34","author":"G Mion","year":"2017","unstructured":"Mion G. History of anaesthesia: The ketamine story - past, present and future. Eur J Anaesthesiol 2017, 34: 571\u2013575.","journal-title":"Eur J Anaesthesiol"},{"key":"1265_CR109","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12264-021-00794-6","volume":"38","author":"H Liu","year":"2022","unstructured":"Liu H, Wu X, Chen J, Fang Y. A breakthrough in understanding the rapid antidepressant effect of ketamine based on structural analysis. Neurosci Bull 2022, 38: 229\u2013231.","journal-title":"Neurosci Bull"},{"key":"1265_CR110","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","volume":"179","author":"M Grabski","year":"2022","unstructured":"Grabski M, McAndrew A, Lawn W, Marsh B, Raymen L, Stevens T, et al. Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder. Am J Psychiatry 2022, 179: 152\u2013162.","journal-title":"Am J Psychiatry"},{"key":"1265_CR111","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry 2014, 71: 681\u2013688.","journal-title":"JAMA Psychiatry"},{"key":"1265_CR112","first-page":"81","volume":"39","author":"W Li","year":"2004","unstructured":"Li W, Wei EQ, Wang ML, Liu LY. Effects of edaravone, minocycline and ONO-1078 on oxygen\/glucose deprivation-induced electrophysiological alteration in rat hippocampal slices. Yao Xue Xue Bao 2004, 39: 81\u201384.","journal-title":"Yao Xue Xue Bao"},{"key":"1265_CR113","first-page":"115","volume":"25","author":"QS Xue","year":"2004","unstructured":"Xue QS, Yu BW, Wang ZJ, Chen HZ. Effects of ketamine, midazolam, thiopental, and propofol on brain ischemia injury in rat cerebral cortical slices. Acta Pharmacol Sin 2004, 25: 115\u2013120.","journal-title":"Acta Pharmacol Sin"},{"key":"1265_CR114","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01616412.2018.1531203","volume":"41","author":"FF Liu","year":"2019","unstructured":"Liu FF, Zhao S, Liu P, Huo SP. Influence of mTOR signaling pathway on ketamine-induced injuries in the hippocampal neurons of rats. Neurol Res 2019, 41: 77\u201386.","journal-title":"Neurol Res"},{"key":"1265_CR115","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2005.10.005","volume":"210","author":"T Takadera","year":"2006","unstructured":"Takadera T, Ishida A, Ohyashiki T. Ketamine-induced apoptosis in cultured rat cortical neurons. Toxicol Appl Pharmacol 2006, 210: 100\u2013107.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1265_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2011.12.021","volume":"677","author":"M Moosavi","year":"2012","unstructured":"Moosavi M, Yadollahi Khales G, Rastegar K, Zarifkar A. The effect of sub-anesthetic and anesthetic ketamine on water maze memory acquisition, consolidation and retrieval. Eur J Pharmacol 2012, 677: 107\u2013110.","journal-title":"Eur J Pharmacol"},{"key":"1265_CR117","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11356-019-06753-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhao J, Chang T, Wang Q, Liu W, Gao L. Ketamine exerts neurotoxic effects on the offspring of pregnant rats via the Wnt\/\u03b2-catenin pathway. Environ Sci Pollut Res Int 2020, 27: 305\u2013314.","journal-title":"Environ Sci Pollut Res Int"},{"key":"1265_CR118","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","volume":"172","author":"Z Tian","year":"2018","unstructured":"Tian Z, Dong C, Fujita A, Fujita Y, Hashimoto K. Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R, S)-ketamine and (S)-ketamine, but not (R)-ketamine. Pharmacol Biochem Behav 2018, 172: 17\u201321.","journal-title":"Pharmacol Biochem Behav"},{"key":"1265_CR119","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12017-017-8472-8","volume":"20","author":"J Zhang","year":"2018","unstructured":"Zhang J, Cui C, Li Y, Xu H. Inhibition of GSK-3beta signaling pathway rescues ketamine-induced neurotoxicity in neural stem cell-derived neurons. Neuromolecular Med 2018, 20: 54\u201362.","journal-title":"Neuromolecular Med"},{"key":"1265_CR120","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.2147\/DDDT.S256319","volume":"14","author":"Y Yao","year":"2020","unstructured":"Yao Y, Wang X, Gao J. LncRNA KCNQ1OT1 sponges miR-206 to ameliorate neural injury induced by anesthesia via up-regulating BDNF. Drug Des Devel Ther 2020, 14: 4789\u20134800.","journal-title":"Drug Des Devel Ther"},{"key":"1265_CR121","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fnmol.2020.00095","volume":"13","author":"Q Chen","year":"2020","unstructured":"Chen Q, Yan J, Xie W, Xie W, Li M, Ye Y. LncRNA LINC00641 sponges miR-497-5p to ameliorate neural injury induced by anesthesia via up-regulating BDNF. Front Mol Neurosci 2020, 13: 95.","journal-title":"Front Mol Neurosci"},{"key":"1265_CR122","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopha.2016.10.094","volume":"85","author":"C Song","year":"2017","unstructured":"Song C, Song C, Chen K, Zhang X. Inhibition of long non-coding RNA IGF2AS protects apoptosis and neuronal loss in anesthetic-damaged mouse neural stem cell derived neurons. Biomed Pharmacother 2017, 85: 218\u2013224.","journal-title":"Biomed Pharmacother"},{"key":"1265_CR123","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000374061","volume":"36","author":"S Zhou","year":"2015","unstructured":"Zhou S, Li M, Zeng D, Xu X, Fei L, Zhu Q, et al. A single nucleotide polymorphism in 3\u2019 untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease. Cell Physiol Biochem 2015, 36: 166\u2013178.","journal-title":"Cell Physiol Biochem"},{"key":"1265_CR124","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2147\/DDDT.S160046","volume":"12","author":"J Liang","year":"2018","unstructured":"Liang J, Wu S, Xie W, He H. Ketamine ameliorates oxidative stress-induced apoptosis in experimental traumatic brain injury via the Nrf2 pathway. Drug Des Devel Ther 2018, 12: 845\u2013853.","journal-title":"Drug Des Devel Ther"},{"key":"1265_CR125","first-page":"871","volume":"30","author":"ID Gursoy","year":"2020","unstructured":"Gursoy ID, Barun S, Erdem SR, Keskin U, Kiziltas M, Atilla P, et al. Investigation of the Possible Protective Effects of Ketamine and Dantrolene on the Hippocampal Apoptosis and Spatial Learning in Rats Exposed to Repeated Electroconvulsive Seizures as a Model of Status Epilepticus. Turk Neurosurg 2020, 30: 871\u2013884.","journal-title":"Turk Neurosurg"},{"key":"1265_CR126","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuro.2019.01.002","volume":"71","author":"CM Loss","year":"2019","unstructured":"Loss CM, da Rosa NS, Mestriner RG, Xavier LL, Oliveira DL. Blockade of GluN2B-containing NMDA receptors reduces short-term brain damage induced by early-life status epilepticus. Neurotoxicology 2019, 71: 138\u2013149.","journal-title":"Neurotoxicology"},{"key":"1265_CR127","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/s41380-018-0083-8","volume":"24","author":"NH Wray","year":"2019","unstructured":"Wray NH, Schappi JM, Singh H, Senese NB, Rasenick MM. NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. Mol Psychiatry 2019, 24: 1833\u20131843.","journal-title":"Mol Psychiatry"},{"key":"1265_CR128","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/mp.2013.66","volume":"19","author":"J Iafrati","year":"2014","unstructured":"Iafrati J, Orejarena MJ, Lassalle O, Bouamrane L, Gonzalez-Campo C, Chavis P. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol Psychiatry 2014, 19: 417\u2013426.","journal-title":"Mol Psychiatry"},{"key":"1265_CR129","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/ALN.0000000000002197","volume":"129","author":"AJ Peters","year":"2018","unstructured":"Peters AJ, Villasana LE, Schnell E. Ketamine alters hippocampal cell proliferation and improves learning in mice after traumatic brain injury. Anesthesiology 2018, 129: 278\u2013295.","journal-title":"Anesthesiology"},{"key":"1265_CR130","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","volume":"167","author":"BK Goulart","year":"2010","unstructured":"Goulart BK, de Lima MNM, de Farias CB, Reolon GK, Almeida VR, Quevedo J, et al. Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels. Neuroscience 2010, 167: 969\u2013973.","journal-title":"Neuroscience"},{"key":"1265_CR131","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/sj.mp.4001957","volume":"12","author":"SA Heldt","year":"2007","unstructured":"Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007, 12: 656\u2013670.","journal-title":"Mol Psychiatry"},{"key":"1265_CR132","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","volume":"22","author":"Y Shirayama","year":"2002","unstructured":"Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22: 3251\u20133261.","journal-title":"J Neurosci"},{"key":"1265_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.881088","volume":"16","author":"G Taheri","year":"2022","unstructured":"Taheri G, Sardari M, Hermann DM, Sepehri H. N-methyl-D-aspartate receptors antagonist prevents secondary ischemic brain injury associated with lipopolysaccharide-induced sepsis-like state presumably via immunomodulatory actions. Front Cell Neurosci 2022, 16: 881088.","journal-title":"Front Cell Neurosci"},{"key":"1265_CR134","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-4886(82)90111-X","volume":"76","author":"J Van Reempts","year":"1982","unstructured":"Van Reempts J, Borgers M, Van Eyndhoven J, Hermans C. Protective effects of etomidate in hypoxic-ischemic brain damage in the rat. A morphologic assessment. Exp Neurol 1982, 76: 181\u2013195.","journal-title":"A morphologic assessment. Exp Neurol"},{"key":"1265_CR135","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1203\/00006450-199511000-00003","volume":"38","author":"GA Taylor","year":"1995","unstructured":"Taylor GA, Trescher WH, Johnston MV, Traystman RJ. Experimental neuronal injury in the newborn lamb: a comparison of N-methyl-D-aspartic acid receptor blockade and nitric oxide synthesis inhibition on lesion size and cerebral hyperemia. Pediatr Res 1995, 38: 644\u2013651.","journal-title":"Pediatr Res"},{"key":"1265_CR136","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1213\/01.ANE.0000146519.85312.21","volume":"100","author":"JC Drummond","year":"2005","unstructured":"Drummond JC, McKay LD, Cole DJ, Patel PM. The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats. Anesth Analg 2005, 100: 841\u2013846.","journal-title":"Anesth Analg"},{"key":"1265_CR137","first-page":"292","volume":"116","author":"L Chen","year":"2003","unstructured":"Chen L, Gong Q, Xiao C. Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. Chin Med J 2003, 116: 292\u2013296.","journal-title":"Chin Med J"},{"key":"1265_CR138","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-3940(02)01193-X","volume":"335","author":"JC Rekling","year":"2003","unstructured":"Rekling JC. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen\/glucose deprivation. Neurosci Lett 2003, 335: 167\u2013170.","journal-title":"Neurosci Lett"},{"key":"1265_CR139","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1124\/jpet.117.247106","volume":"367","author":"X Wu","year":"2018","unstructured":"Wu X, Kuruba R, Reddy DS. Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents. J Pharmacol Exp Ther 2018, 367: 302\u2013321.","journal-title":"J Pharmacol Exp Ther"},{"key":"1265_CR140","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s13181-017-0650-4","volume":"14","author":"P Anantharam","year":"2018","unstructured":"Anantharam P, Kim DS, Whitley EM, Mahama B, Imerman P, Padhi P, et al. Midazolam efficacy against acute hydrogen sulfide-induced mortality and neurotoxicity. J Med Toxicol 2018, 14: 79\u201390.","journal-title":"J Med Toxicol"},{"key":"1265_CR141","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.neuroscience.2018.03.040","volume":"388","author":"Y Li","year":"2018","unstructured":"Li Y, Li X, Zhao J, Li L, Wang Y, Zhang Y, et al. Midazolam attenuates autophagy and apoptosis caused by ketamine by decreasing reactive oxygen species in the hippocampus of fetal rats. Neuroscience 2018, 388: 460\u2013471.","journal-title":"Neuroscience"},{"key":"1265_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tice.2019.03.001","volume":"58","author":"D Yu","year":"2019","unstructured":"Yu D, Zhu Y, Cui C, Long R, Ma J. Midazolam prevents sevoflurane-induced death in hippocampal neurons. Tissue Cell 2019, 58: 1\u20137.","journal-title":"Tissue Cell"},{"key":"1265_CR143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuint.2019.04.018","volume":"128","author":"GL Mazzone","year":"2019","unstructured":"Mazzone GL, Nistri A. Modulation of extrasynaptic GABAergic receptor activity influences glutamate release and neuronal survival following excitotoxic damage to mouse spinal cord neurons. Neurochem Int 2019, 128: 175\u2013185.","journal-title":"Neurochem Int"},{"key":"1265_CR144","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainresbull.2020.04.016","volume":"161","author":"Z Tang","year":"2020","unstructured":"Tang Z, Yang F, Dong Y, Ma C, Sun S, Shan Y, et al. Midazolam contributes to neuroprotection against hypoxia\/reoxygenation-induced brain injury in neonatal rats via regulation of EAAT2. Brain Res Bull 2020, 161: 136\u2013146.","journal-title":"Brain Res Bull"},{"key":"1265_CR145","first-page":"443","volume":"43","author":"H Yu","year":"2019","unstructured":"Yu H, Wang X, Kang F, Chen Z, Meng Y, Dai M. Neuroprotective effects of midazolam on focal cerebral ischemia in rats through anti-apoptotic mechanisms. Int J Mol Med 2019, 43: 443\u2013451.","journal-title":"Int J Mol Med"},{"key":"1265_CR146","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12871-022-01592-x","volume":"22","author":"A Sebastiani","year":"2022","unstructured":"Sebastiani A, Bender S, Sch\u00e4fer MKE, Thal SC. Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injury. BMC Anesthesiol 2022, 22: 60.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR147","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00228-020-02984-z","volume":"76","author":"M Pesic","year":"2020","unstructured":"Pesic M, Schippers F, Saunders R, Webster L, Donsbach M, Stoehr T. Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial. Eur J Clin Pharmacol 2020, 76: 1505\u20131516.","journal-title":"Eur J Clin Pharmacol"},{"key":"1265_CR148","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/jcph.1614","volume":"60","author":"F Schippers","year":"2020","unstructured":"Schippers F, Pesic M, Saunders R, Borkett K, Searle S, Webster L, et al. Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users. J Clin Pharmacol 2020, 60: 1189\u20131197.","journal-title":"J Clin Pharmacol"},{"key":"1265_CR149","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/DDDT.S344240","volume":"16","author":"M Shi","year":"2022","unstructured":"Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen L, et al. Protective effects of remimazolam on cerebral ischemia\/reperfusion injury in rats by inhibiting of NLRP3 inflammasome-dependent pyroptosis. Drug Des Devel Ther 2022, 16: 413\u2013423.","journal-title":"Drug Des Devel Ther"},{"key":"1265_CR150","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1515\/tnsci-2022-0220","volume":"13","author":"XH Zhou","year":"2022","unstructured":"Zhou XH, Zhang CC, Wang L, Jin SL. Remimazolam induced cognitive dysfunction in mice via glutamate excitotoxicity. Transl Neurosci 2022, 13: 104\u2013115.","journal-title":"Transl Neurosci"},{"key":"1265_CR151","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1213\/ANE.0000000000003420","volume":"127","author":"J Chui","year":"2018","unstructured":"Chui J, Murkin JM, Posner KL, Domino KB. Perioperative peripheral nerve injury after general anesthesia: A qualitative systematic review. Anesth Analg 2018, 127: 134\u2013143.","journal-title":"Anesth Analg"},{"key":"1265_CR152","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0304-3959(92)90158-8","volume":"50","author":"R Casale","year":"1992","unstructured":"Casale R, Glynn C, Buonocore M. The role of ischaemia in the analgesia which follows Bier\u2019s Block technique. Pain 1992, 50: 169\u2013175.","journal-title":"Pain"},{"key":"1265_CR153","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/00000542-199006000-00014","volume":"72","author":"C Chabel","year":"1990","unstructured":"Chabel C, Russell LC, Lee R. Tourniquet-induced limb ischemia: A neurophysiologic animal model. Anesthesiology 1990, 72: 1038\u20131044.","journal-title":"Anesthesiology"},{"key":"1265_CR154","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12871-022-01702-9","volume":"22","author":"C Karam","year":"2022","unstructured":"Karam C, Al Assadi S, Kanazi G, Zeeni C. A sequential allocation study to determine the ED50 of Dexmedetomidine as an adjuvant to lidocaine intravenous regional anesthesia. BMC Anesthesiol 2022, 22: 165.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR155","first-page":"314","volume":"16","author":"JC Crews","year":"1991","unstructured":"Crews JC, Hilgenhurst G, Leavitt B, Denson DD, Bridenbaugh PO, Stuebing RC. Tourniquet pain: The response to the maintenance of tourniquet inflation on the upper extremity of volunteers. Reg Anesth 1991, 16: 314\u2013317.","journal-title":"Reg Anesth"},{"key":"1265_CR156","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5152\/balkanmedj.2021.20076","volume":"38","author":"I Karmaniolou","year":"2021","unstructured":"Karmaniolou I, Staikou C, Surda P. The role of dexmedetomidine as an additive to intravenous regional anesthesia: A systematic review and meta-analysis. Balkan Med J 2021, 38: 156\u2013164.","journal-title":"Balkan Med J"},{"key":"1265_CR157","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4103\/0259-1162.206851","volume":"11","author":"V Subramanya","year":"2017","unstructured":"Subramanya V, Kapinigowda ST, Math AT, Chennaiah VB. Dexmedetomidine as an adjuvant for intravenous regional anesthesia in upper limb surgeries. Anesth Essays Res 2017, 11: 661\u2013664.","journal-title":"Anesth Essays Res"},{"key":"1265_CR158","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.36740\/WLek202109203","volume":"74","author":"DS Sami","year":"2021","unstructured":"Sami DS, Muslih AH. A comparative study of two different doses of dexmedetomidine as adjunct to lidocaine in intravenous regional anesthesia. Wiad Lek 2021, 74: 2259\u20132264.","journal-title":"Wiad Lek"},{"key":"1265_CR159","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/ALN.0000000000000557","volume":"122","author":"C Zhou","year":"2015","unstructured":"Zhou C, Ke B, Zhao Y, Liang P, Liao D, Li T, et al. Hyperpolarization-activated cyclic nucleotide-gated channels may contribute to regional anesthetic effects of lidocaine. Anesthesiology 2015, 122: 606\u2013618.","journal-title":"Anesthesiology"},{"key":"1265_CR160","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2147\/JPR.S139387","volume":"10","author":"C Tang","year":"2017","unstructured":"Tang C, Xia Z. Dexmedetomidine in perioperative acute pain management: A non-opioid adjuvant analgesic. J Pain Res 2017, 10: 1899\u20131904.","journal-title":"J Pain Res"},{"key":"1265_CR161","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12871-024-02453-5","volume":"24","author":"D Wang","year":"2024","unstructured":"Wang D, He X, Li Z, Tao H, Bi C. The role of dexmedetomidine administered via intravenous infusion as adjunctive therapy to mitigate postoperative delirium and postoperative cognitive dysfunction in elderly patients undergoing regional anesthesia: A meta-analysis of randomized controlled trials. BMC Anesthesiol 2024, 24: 73.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR162","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.25011\/cim.v36i2.19572","volume":"36","author":"A T\u00fcfek","year":"2013","unstructured":"T\u00fcfek A, Kaya S, Tokg\u00f6z O, Firat U, Evliyao\u011flu O, \u00c7elik F, et al. The protective effect of dexmedetomidine on bupivacaine-induced sciatic nerve inflammation is mediated by mast cells. Clin Invest Med 2013, 36: E95\u2013E102.","journal-title":"Clin Invest Med"},{"key":"1265_CR163","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3390\/ijms15034049","volume":"15","author":"Y Huang","year":"2014","unstructured":"Huang Y, Lu Y, Zhang L, Yan J, Jiang J, Jiang H. Perineural dexmedetomidine attenuates inflammation in rat sciatic nerve via the NF-\u03baB pathway. Int J Mol Sci 2014, 15: 4049\u20134059.","journal-title":"Int J Mol Sci"},{"key":"1265_CR164","doi-asserted-by":"publisher","first-page":"9045608","DOI":"10.1155\/2017\/9045608","volume":"2017","author":"W Jeong","year":"2017","unstructured":"Jeong W, Kung H, Cheng CC, Lim C, Jung MJ, Lee J, et al. Dexmedetomidine to help nerve regeneration in a rat sciatic nerve injury model. Pain Res Manag 2017, 2017: 9045608.","journal-title":"Pain Res Manag"},{"key":"1265_CR165","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.etp.2016.09.001","volume":"68","author":"E Memari","year":"2016","unstructured":"Memari E, Hosseinian MA, Mirkheshti A, Arhami-Dolatabadi A, Mirabotalebi M, Khandaghy M, et al. Comparison of histopathological effects of perineural administration of bupivacaine and bupivacaine-dexmedetomidine in rat sciatic nerve. Exp Toxicol Pathol 2016, 68: 559\u2013564.","journal-title":"Exp Toxicol Pathol"},{"key":"1265_CR166","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bja.2018.08.022","volume":"122","author":"ZY Yu","year":"2019","unstructured":"Yu ZY, Geng J, Li ZQ, Sun YB, Wang SL, Masters J, et al. Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats. Br J Anaesth 2019, 122: 141\u2013149.","journal-title":"Br J Anaesth"},{"key":"1265_CR167","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/rapm-2020-102353","volume":"46","author":"N Hussain","year":"2021","unstructured":"Hussain N, Brummett CM, Brull R, Alghothani Y, Moran K, Sawyer T, et al. Efficacy of perineural versus intravenous dexmedetomidine as a peripheral nerve block adjunct: A systematic review. Reg Anesth Pain Med 2021, 46: 704\u2013712.","journal-title":"Reg Anesth Pain Med"},{"key":"1265_CR168","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/00000542-200411000-00005","volume":"101","author":"YW Hsu","year":"2004","unstructured":"Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics: Part I: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004, 101: 1066\u20131076.","journal-title":"Anesthesiology"},{"key":"1265_CR169","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","volume":"93","author":"TJ Ebert","year":"2000","unstructured":"Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000, 93: 382\u2013394.","journal-title":"Anesthesiology"},{"key":"1265_CR170","first-page":"488","volume":"43","author":"R Kang","year":"2018","unstructured":"Kang R, Jeong JS, Yoo JC, Lee JH, Choi SJ, Gwak MS, et al. Effective dose of intravenous dexmedetomidine to prolong the analgesic duration of interscalene brachial plexus block: A single-center, prospective, double-blind, randomized controlled trial. Reg Anesth Pain Med 2018, 43: 488\u2013495.","journal-title":"Reg Anesth Pain Med"},{"key":"1265_CR171","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1358\/mf.2006.28.8.1003547","volume":"28","author":"OL Erhan","year":"2006","unstructured":"Erhan OL, Bestas A, Gursu F, Alpay N, Ozer AB, Gulcu F. The effect of propofol as an antioxidant agent in intravenous regional anesthesia. Methods Find Exp Clin Pharmacol 2006, 28: 523\u2013526.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"1265_CR172","first-page":"2520","volume":"8","author":"Y Sun","year":"2013","unstructured":"Sun Y, Zhang X, Zhou Q, Wang YA, Jiang Y, Cao J. Propofol\u2019s effect on the sciatic nerve: Harmful or protective? Neural Regen Res 2013, 8: 2520\u20132530.","journal-title":"Neural Regen Res"},{"key":"1265_CR173","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/cjn.2016.424","volume":"44","author":"PA Abdelmalik","year":"2017","unstructured":"Abdelmalik PA, Rakocevic G. Propofol as a risk factor for ICU-acquired weakness in septic patients with acute respiratory failure. Can J Neurol Sci 2017, 44: 295\u2013303.","journal-title":"Can J Neurol Sci"},{"key":"1265_CR174","first-page":"352","volume":"65","author":"Y Fujita","year":"2016","unstructured":"Fujita Y, Nakamoto A, Inoue M, Hayashi Y, Shimizu M, Hotta A, et al. Anesthetic management with propofol alone in a patient with hereditary sensory and autonomic neuropathy. Masui 2016, 65: 352\u2013355.","journal-title":"Masui"},{"key":"1265_CR175","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/rapm.2001.27857","volume":"26","author":"NK Gorgias","year":"2001","unstructured":"Gorgias NK, Maidatsi PG, Kyriakidis AM, Karakoulas KA, Alvanos DN, Giala MM. Clonidine versus ketamine to prevent tourniquet pain during intravenous regional anesthesia with lidocaine. Reg Anesth Pain Med 2001, 26: 512\u2013517.","journal-title":"Reg Anesth Pain Med"},{"key":"1265_CR176","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1365-2044.1985.tb11056.x","volume":"40","author":"JF Amiot","year":"1985","unstructured":"Amiot JF, Bouju P, Palacci JH, Balliner E. Intravenous regional anaesthesia with ketamine. Anaesthesia 1985, 40: 899\u2013901.","journal-title":"Anaesthesia"},{"key":"1265_CR177","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1213\/00000539-198903000-00026","volume":"68","author":"Z Durrani","year":"1989","unstructured":"Durrani Z, Winnie AP, Zsigmond EK, Burnett ML. Ketamine for intravenous regional anesthesia. Anesth Analg 1989, 68: 328\u2013332.","journal-title":"Anesth Analg"},{"key":"1265_CR178","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1213\/ANE.0000000000000246","volume":"119","author":"J Sawynok","year":"2014","unstructured":"Sawynok J. Topical and peripheral ketamine as an analgesic. Anesth Analg 2014, 119: 170\u2013178.","journal-title":"Anesth Analg"},{"key":"1265_CR179","doi-asserted-by":"crossref","unstructured":"De Kock M, Lavand\u2019homme P, Waterloos H. \u2018Balanced analgesia\u2019 in the perioperative period: Is there a place for ketamine? Pain 2001, 92: 373\u2013380.","DOI":"10.1016\/S0304-3959(01)00278-0"},{"key":"1265_CR180","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ph17010016","volume":"17","author":"K Savi\u0107 Vujovi\u0107","year":"2023","unstructured":"Savi\u0107 Vujovi\u0107 K, Joti\u0107 A, Medi\u0107 B, Srebro D, Vujovi\u0107 A, \u017dujovi\u0107 J, et al. Ketamine, an old-new drug: Uses and abuses. Pharmaceuticals 2023, 17: 16.","journal-title":"Pharmaceuticals"},{"key":"1265_CR181","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2147\/IJN.S400798","volume":"18","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhou P, Jiang Y, Li L, Ju F, Cheng Q, et al. Sustained-release esketamine based nanoparticle-hydrogel delivery system for neuropathic pain management. Int J Nanomedicine 2023, 18: 1131\u20131143.","journal-title":"Int J Nanomedicine"},{"key":"1265_CR182","first-page":"22","volume":"3","author":"RA Sunder","year":"2008","unstructured":"Sunder RA, Toshniwal G, Dureja GP. Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury. J Brachial Plex Peripher Nerve Inj 2008, 3: 22.","journal-title":"J Brachial Plex Peripher Nerve Inj"},{"key":"1265_CR183","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/j.1464-410X.2012.11028.x","volume":"110","author":"AR Winstock","year":"2012","unstructured":"Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 2012, 110: 1762\u20131766.","journal-title":"BJU Int"},{"key":"1265_CR184","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.toxlet.2009.09.006","volume":"191","author":"LY Yeung","year":"2009","unstructured":"Yeung LY, Rudd JA, Lam WP, Mak YT, Yew DT. Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol Lett 2009, 191: 275\u2013278.","journal-title":"Toxicol Lett"},{"key":"1265_CR185","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2011.04.022","volume":"661","author":"O Kekesi","year":"2011","unstructured":"Kekesi O, Tuboly G, Szucs M, Birkas E, Morvay Z, Benedek G, et al. Long-lasting, distinct changes in central opioid receptor and urinary bladder functions in models of schizophrenia in rats. Eur J Pharmacol 2011, 661: 35\u201341.","journal-title":"Eur J Pharmacol"},{"key":"1265_CR186","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.juro.2011.04.102","volume":"186","author":"E Meng","year":"2011","unstructured":"Meng E, Chang HY, Chang SY, Sun GH, Yu DS, Cha TL. Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction. J Urol 2011, 186: 1134\u20131141.","journal-title":"J Urol"},{"key":"1265_CR187","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/aas.12356","volume":"58","author":"X Duan","year":"2014","unstructured":"Duan X, Li Y, Zhou C, Huang L, Dong Z. Dexmedetomidine provides neuroprotection: Impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiol Scand 2014, 58: 1121\u20131126.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1265_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093639","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Zeng M, Chen W, Liu C, Wang F, Han X, et al. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K\/Akt pathway in the hippocampus of neonatal rats. PLoS One 2014, 9: e93639.","journal-title":"PLoS One"},{"key":"1265_CR189","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/bja\/aex222","volume":"119","author":"JF Perez-Zoghbi","year":"2017","unstructured":"Perez-Zoghbi JF, Zhu W, Grafe MR, Brambrink AM. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats. Br J Anaesth 2017, 119: 506\u2013516.","journal-title":"Br J Anaesth"},{"key":"1265_CR190","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00540-018-2545-1","volume":"32","author":"LJ Bo","year":"2018","unstructured":"Bo LJ, Yu PX, Zhang FZ, Dong ZM. Dexmedetomidine mitigates sevoflurane-induced cell cycle arrest in hippocampus. J Anesth 2018, 32: 717\u2013724.","journal-title":"J Anesth"},{"key":"1265_CR191","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40360-022-00555-9","volume":"23","author":"Z Chen","year":"2022","unstructured":"Chen Z, Ding Y, Zeng Y, Zhang XP, Chen JY. Dexmedetomidine reduces propofol-induced hippocampal neuron injury by modulating the miR-377-5p\/Arc pathway. BMC Pharmacol Toxicol 2022, 23: 18.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1265_CR192","doi-asserted-by":"publisher","first-page":"9543459","DOI":"10.1155\/2022\/9543459","volume":"2022","author":"X Yin","year":"2022","unstructured":"Yin X, Jiang P, Li J. Dexmedetomidine combined with low-dose propofol declines learning and memory impairment and neural cell injury in developing rats. Evid Based Complement Alternat Med 2022, 2022: 9543459.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1265_CR193","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1021\/acschemneuro.9b00611","volume":"11","author":"S Lei","year":"2020","unstructured":"Lei S, Lu P, Lu Y, Zheng J, Li W, Wang N, et al. Dexmedetomidine alleviates neurogenesis damage following neonatal midazolam exposure in rats through JNK and P38 MAPK pathways. ACS Chem Neurosci 2020, 11: 579\u2013591.","journal-title":"ACS Chem Neurosci"},{"key":"1265_CR194","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/EJA.0000000000001532","volume":"38","author":"PH Chen","year":"2021","unstructured":"Chen PH, Tsuang FY, Lee CT, Yeh YC, Cheng HL, Lee TS, et al. Neuroprotective effects of intraoperative dexmedetomidine versus saline infusion combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery: A randomised controlled trial. Eur J Anaesthesiol 2021, 38: 1262\u20131271.","journal-title":"Eur J Anaesthesiol"},{"key":"1265_CR195","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.1505","volume":"152","author":"S Deiner","year":"2017","unstructured":"Deiner S, Luo X, Lin HM, Sessler DI, Saager L, Sieber FE, et al. Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: A randomized clinical trial. JAMA Surg 2017, 152: e171505.","journal-title":"JAMA Surg"},{"key":"1265_CR196","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12871-015-0130-9","volume":"15","author":"Y Qiao","year":"2015","unstructured":"Qiao Y, Feng H, Zhao T, Yan H, Zhang H, Zhao X. Postoperative cognitive dysfunction after inhalational anesthesia in elderly patients undergoing major surgery: The influence of anesthetic technique, cerebral injury and systemic inflammation. BMC Anesthesiol 2015, 15: 154.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR197","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0028-3886.136908","volume":"62","author":"C Mahajan","year":"2014","unstructured":"Mahajan C, Chouhan RS, Rath GP, Dash HH, Suri A, Chandra PS, et al. Effect of intraoperative brain protection with propofol on postoperative cognition in patients undergoing temporary clipping during intracranial aneurysm surgery. Neurol India 2014, 62: 262\u2013268.","journal-title":"Neurol India"},{"key":"1265_CR198","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1176\/appi.focus.23021014","volume":"21","author":"A Feder","year":"2023","unstructured":"Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Focus 2023, 21: 296\u2013305.","journal-title":"Focus"},{"key":"1265_CR199","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47: 351\u2013354.","journal-title":"Biol Psychiatry"},{"key":"1265_CR200","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1375\/twin.12.3.246","volume":"12","author":"M Bartels","year":"2009","unstructured":"Bartels M, Althoff RR, Boomsma DI. Anesthesia and cognitive performance in children: No evidence for a causal relationship. Twin Res Hum Genet 2009, 12: 246\u2013253.","journal-title":"Twin Res Hum Genet"},{"key":"1265_CR201","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jphs.2018.04.001","volume":"137","author":"S Jiang","year":"2018","unstructured":"Jiang S, Wu Y, Fang DF, Chen Y. Hypothermic preconditioning but not ketamine reduces oxygen and glucose deprivation induced neuronal injury correlated with downregulation of COX-2 expression in mouse hippocampal slices. J Pharmacol Sci 2018, 137: 30\u201337.","journal-title":"J Pharmacol Sci"},{"key":"1265_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110948","volume":"133","author":"LFN Dourado","year":"2021","unstructured":"Dourado LFN, Oliveira LG, da Silva CN, Toledo CR, Fialho SL, Jorge R, et al. Intravitreal ketamine promotes neuroprotection in rat eyes after experimental ischemia. Biomedecine Pharmacother 2021, 133: 110948.","journal-title":"Biomedecine Pharmacother"},{"key":"1265_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.173079","volume":"200","author":"R Liu","year":"2021","unstructured":"Liu R, Wu XM, He X, Wang RZ, Yin XY, Zhou F, et al. Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: Reversal by ketamine. Pharmacol Biochem Behav 2021, 200: 173079.","journal-title":"Pharmacol Biochem Behav"},{"key":"1265_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136251","volume":"765","author":"AE Pottenger","year":"2021","unstructured":"Pottenger AE, Bartlett MJ, Sherman SJ, Falk T, Morrison HW. Evaluation of microglia in a rodent model of Parkinson\u2019s disease primed with L-DOPA after sub-anesthetic ketamine treatment. Neurosci Lett 2021, 765: 136251.","journal-title":"Neurosci Lett"},{"key":"1265_CR205","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/j.semtcvs.2021.12.004","volume":"35","author":"K Giuliano","year":"2023","unstructured":"Giuliano K, Etchill E, Velez AK, Wilson MA, Blue ME, Troncoso JC, et al. Ketamine mitigates neurobehavioral deficits in a canine model of hypothermic circulatory arrest. Semin Thorac Cardiovasc Surg 2023, 35: 251\u2013258.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"1265_CR206","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12871-019-0884-6","volume":"19","author":"V Kuklin","year":"2019","unstructured":"Kuklin V, Akhatov N, Kondratiev T, Konkayev A, Baigenzhin A, Konkayeva M, et al. The influences of morphine or ketamine pre-treatment on hemodynamic, acid-base status, biochemical markers of brain damage and early survival in rats after asphyxial cardiac arrest. BMC Anesthesiol 2019, 19: 214.","journal-title":"BMC Anesthesiol"},{"key":"1265_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110308","volume":"73","author":"C Qin","year":"2021","unstructured":"Qin C, Jiang Y, Lin C, Li A, Liu J. Perioperative dexmedetomidine administration to prevent delirium in adults after non-cardiac surgery: A systematic review and meta-analysis. J Clin Anesth 2021, 73: 110308.","journal-title":"J Clin Anesth"},{"key":"1265_CR208","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/03009734.2013.808295","volume":"118","author":"L Yang","year":"2013","unstructured":"Yang L, Xu JM, Jiang X, Ruan W, Cui Y, He L. Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A double-blind, randomized and placebo-controlled study. Ups J Med Sci 2013, 118: 235\u2013239.","journal-title":"Ups J Med Sci"},{"key":"1265_CR209","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.clineuro.2016.05.004","volume":"146","author":"X Luo","year":"2016","unstructured":"Luo X, Zheng X, Huang H. Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism. Clin Neurol Neurosurg 2016, 146: 105\u2013108.","journal-title":"Clin Neurol Neurosurg"},{"key":"1265_CR210","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.bja.2019.06.026","volume":"123","author":"AF Zuppa","year":"2019","unstructured":"Zuppa AF, Nicolson SC, Wilder NS, Ibla JC, Gottlieb EA, Burns KM, et al. Results of a phase 1 multicentre investigation of dexmedetomidine bolus and infusion in corrective infant cardiac surgery. Br J Anaesth 2019, 123: 839\u2013852.","journal-title":"Br J Anaesth"},{"key":"1265_CR211","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15217","volume":"5","author":"XS Shan","year":"2022","unstructured":"Shan XS, Hu LK, Wang Y, Liu HY, Chen J, Meng XW, et al. Effect of perioperative dexmedetomidine on delayed graft function following a donation-after-cardiac-death kidney transplant: A randomized clinical trial. JAMA Netw Open 2022, 5: e2215217.","journal-title":"JAMA Netw Open"},{"key":"1265_CR212","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00207454.2018.1483920","volume":"129","author":"D Guo","year":"2019","unstructured":"Guo D, Li Y, Wang H, Wang X, Hua W, Tang Q, et al. Propofol post-conditioning after temporary clipping reverses oxidative stress in aneurysm surgery. Int J Neurosci 2019, 129: 155\u2013164.","journal-title":"Int J Neurosci"},{"key":"1265_CR213","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1176\/appi.focus.22020004","volume":"20","author":"JB Dwyer","year":"2022","unstructured":"Dwyer JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, Flores JM, Nasir M, et al. Efficacy of intravenous ketamine in adolescent treatment-resistant depression: A randomized midazolam-controlled trial. Focus 2022, 20: 241\u2013251.","journal-title":"Focus"},{"key":"1265_CR214","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067194","volume":"376","author":"M Abbar","year":"2022","unstructured":"Abbar M, Demattei C, El-Hage W, Llorca PM, Samalin L, Demaricourt P, et al. Ketamine for the acute treatment of severe suicidal ideation: Double blind, randomised placebo controlled trial. BMJ 2022, 376: e067194.","journal-title":"BMJ"},{"key":"1265_CR215","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11064-021-03461-4","volume":"47","author":"S Zhao","year":"2022","unstructured":"Zhao S, Cheng WJ, Liu X, Li Z, Li HZ, Shi N, et al. Effects of dexmedetomidine and oxycodone on neurocognitive and inflammatory response after tourniquet-induced ischemia\u2013reperfusion injury. Neurochem Res 2022, 47: 461\u2013469.","journal-title":"Neurochem Res"},{"key":"1265_CR216","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/jir.2019.0110","volume":"40","author":"J Xiong","year":"2020","unstructured":"Xiong J, Quan J, Qin C, Wang X, Dong Q, Zhang B. Dexmedetomidine exerts brain-protective effects under cardiopulmonary bypass through inhibiting the Janus kinase 2\/signal transducers and activators of transcription 3 pathway. J Interferon Cytokine Res 2020, 40: 116\u2013124.","journal-title":"J Interferon Cytokine Res"},{"key":"1265_CR217","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/08923973.2021.1942901","volume":"43","author":"JJ Yang","year":"2021","unstructured":"Yang JJ, Zhao YH, Yin KW, Zhang XQ, Liu J. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic\/reperfusion. Immunopharmacol Immunotoxicol 2021, 43: 478\u2013486.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1265_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2018.05.040","volume":"1698","author":"D Yin","year":"2018","unstructured":"Yin D, Zhou S, Xu X, Gao W, Li F, Ma Y, et al. Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: The TLR4\/NF-\u03baB pathway and the NLRP3 inflammasome may be involved in the mechanism. Brain Res 2018, 1698: 1\u201310.","journal-title":"Brain Res"},{"key":"1265_CR219","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainresbull.2021.10.016","volume":"178","author":"G Hu","year":"2022","unstructured":"Hu G, Shi Z, Shao W, Xu B. MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer\u2019s disease via targeting the suppressor of zest 12. Brain Res Bull 2022, 178: 164\u2013172.","journal-title":"Brain Res Bull"},{"key":"1265_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116611","volume":"232","author":"Y Gao","year":"2019","unstructured":"Gao Y, Yin H, Zhang Y, Dong Y, Yang F, Wu X, et al. Dexmedetomidine protects hippocampal neurons against hypoxia\/reoxygenation-induced apoptosis through activation HIF-1\u03b1\/p53 signaling. Life Sci 2019, 232: 116611.","journal-title":"Life Sci"},{"key":"1265_CR221","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00008506-200004000-00003","volume":"12","author":"S Himmelseher","year":"2000","unstructured":"Himmelseher S, Pfenninger E, Kochs E, Auchter M. S(+)-ketamine up-regulates neuronal regeneration associated proteins following glutamate injury in cultured rat hippocampal neurons. J Neurosurg Anesthesiol 2000, 12: 84\u201394.","journal-title":"J Neurosurg Anesthesiol"},{"key":"1265_CR222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170496","volume":"12","author":"S Mansouri","year":"2017","unstructured":"Mansouri S, Agartz I, \u00d6gren SO, Patrone C, Lundberg M. PACAP protects adult neural stem cells from the neurotoxic effect of ketamine associated with decreased apoptosis, ER stress and mTOR pathway activation. PLoS One 2017, 12: e0170496.","journal-title":"PLoS One"},{"key":"1265_CR223","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/cbin.10349","volume":"39","author":"SE Cao","year":"2015","unstructured":"Cao SE, Tian J, Chen S, Zhang X, Zhang Y. Role of miR-34c in ketamine-induced neurotoxicity in neonatal mice hippocampus. Cell Biol Int 2015, 39: 164\u2013168.","journal-title":"Cell Biol Int"},{"key":"1265_CR224","doi-asserted-by":"crossref","unstructured":"Cui L, Jiang X, Zhang C, Li D, Yu S, Wan F, et al. Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3\/TXNIP Aix. Biosci Rep 2019, 39: BSR20190595.","DOI":"10.1042\/BSR20190595"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01265-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-024-01265-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01265-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:31:57Z","timestamp":1737102717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-024-01265-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":224,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1007\/s12264-024-01265-4","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}